Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr 19;11(4):e0153429.
doi: 10.1371/journal.pone.0153429. eCollection 2016.

Association of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart Study

Yejin Mok  1   2 , Kunihiro Matsushita  1 , Yingying Sang  1 , Shoshana H Ballew  1 , Morgan Grams  1 , Sang Yop Shin  3 , Sun Ha Jee  2 , Josef Coresh  1
Affiliations

Association of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart Study

Yejin Mok et al. PLoS One. .

Abstract

Background: The link of low estimated glomerular filtration rate (eGFR) and high proteinuria to cardiovascular disease (CVD) mortality is well known. However, its link to mortality due to other causes is less clear.

Methods: We studied 367,932 adults (20-93 years old) in the Korean Heart Study (baseline between 1996-2004 and follow-up until 2011) and assessed the associations of creatinine-based eGFR and dipstick proteinuria with mortality due to CVD (1,608 cases), cancer (4,035 cases), and other (non-CVD/non-cancer) causes (3,152 cases) after adjusting for potential confounders.

Results: Although cancer was overall the most common cause of mortality, in participants with chronic kidney disease (CKD), non-CVD/non-cancer mortality accounted for approximately half of cause of death (47.0%for eGFR <60 ml/min/1.73 m2 and 54.3% for proteinuria ≥1+). Lower eGFR (<60 vs. ≥60 ml/min/1.73 m2) was significantly associated with mortality due to CVD (adjusted hazard ratio 1.49 [95% CI, 1.24-1.78]) and non-CVD/non-cancer causes (1.78 [1.54-2.05]). The risk of cancer mortality only reached significance at eGFR <45 ml/min/1.73 m2 when eGFR 45-59 ml/min/1.73 m2 was set as a reference (1.62 [1.10-2.39]). High proteinuria (dipstick ≥1+ vs. negative/trace) was consistently associated with mortality due to CVD (1.93 [1.66-2.25]), cancer (1.49 [1.32-1.68]), and other causes (2.19 [1.96-2.45]). Examining finer mortality causes, low eGFR and high proteinuria were commonly associated with mortality due to coronary heart disease, any infectious disease, diabetes, and renal failure. In addition, proteinuria was also related to death from stroke, cancers of stomach, liver, pancreas, and lung, myeloma, pneumonia, and viral hepatitis.

Conclusion: Low eGFR was associated with CVD and non-CVD/non-cancer mortality, whereas higher proteinuria was consistently related to mortality due to CVD, cancer, and other causes. These findings suggest the need for multidisciplinary prevention and management strategies in individuals with CKD, particularly when proteinuria is present.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Age-standardized mortality rate (per 1000 person-years) by eGFR.
Fig 2
Fig 2. Age-standardized mortality rate (per 1000 person-years) by dipstick proteinuria.
Fig 3
Fig 3. Adjusted hazard ratios of cause-specific mortality for eGFR<60 ml/min/1.73m2 (vs.≥60).
Fig 4
Fig 4. Adjusted hazard ratios of cause-specific mortality for positive dipstick proteinuria (≥+ vs. none/trace).
See this image and copyright information in PMC

References

    1. Health NIo. USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, 2013. http://www.usrds.org/atlas.aspx: U.S. Renal Data System; 2013 [cited 2014 June 27]. Available from: http://www.usrds.org/atlas.aspx.
    1. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72. 10.1016/S0140-6736(13)60687-X . - DOI - PubMed
    1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA: the journal of the American Medical Association. 2007;298(17):2038–47. 10.1001/jama.298.17.2038 . - DOI - PubMed
    1. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–22. 10.1016/S0140-6736(12)60033-6 . - DOI - PubMed
    1. Arora P, Vasa P, Brenner D, Iglar K, McFarlane P, Morrison H, et al. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne. 2013;185(9):E417–23. 10.1503/cmaj.120833 - DOI - PMC - PubMed

Publication types

MeSH terms